Promising Therapy of XDR-TB/MDR-TB with Thioridazine an Inhibitor of Bacterial Efflux Pumps

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|9|9|816-819

ISSN： 1389-4501

Source： Current Drug Targets, Vol.9, Iss.9, 2008-09, pp. : 816-819

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aggressive approach yields positive results for XDR TB

By  

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Efflux pumps: an answer to Gram-negative bacterial resistance?

By Wiggins Phillip  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 8, 2004-08 ,pp. : 899-902

Informa Healthcare

Access to resources Recommend Favorite

Alternative, rapid DST methods cost effective in MDR TB

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 559, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

New Methods for the Identification of Efflux Mediated MDR Bacteria, Genetic Assessment of Regulators and Efflux Pump Constituents, Characterization of Efflux Systems and Screening for Inhibitors of Efflux Pumps

By  

Current Drug Targets, Vol. 9, Iss. 9, 2008-09 ,pp. : 760-778

Bentham Science Publishers

Access to resources Recommend Favorite

The Evolution of Extensively Drug Resistant Tuberculosis (XDR-TB): History, Status and Issues for Global Control

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 73-91

Bentham Science Publishers

Access to resources Recommend Favorite